Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy

User rating: 5 / 5 after 2 vote(s)

A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal Nature.


Full story »

All News summaries from Medicine & Health news
All News summaries for February 10, 2008

Just a numbers game? Making sense of health statistics

2 hours ago | User rating: not rated yet
Presidential candidates use them to persuade voters, drug companies use them to sell their products, and the media spin them in all kinds of ways, but nobody - candidates, reporters, let alone health consumers - understands ...

Statins may prevent miscarriages

5 hours ago | User rating: not rated yet
Hospital for Special Surgery researchers have found that statins may be able to prevent miscarriages in women who are suffering from pregnancy complications caused by antiphospholipid syndrome (APS), according to a study ...

A link between mitochondria and tumor formation in stem cells

6 hours ago | User rating: not rated yet
Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria –a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity ...

Researcher eliminates viral vector in stem cell reprogramming

6 hours ago | User rating: not rated yet
Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent ...

On the trail of a targeted therapy for blood cancers

7 hours ago | User rating: not rated yet
Investigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic ...